The first of our innovations
Has recently received approval as a medical device in the European Union. ENHALE has been designed to help adult smokers to quit smoking by alleviating nicotine withdrawal symptoms.
Using state of the art technology linking the consumer to their treatment, ENHALE is undergoing regulatory approval.
We have been working hard to
develop the next generation of
safer nicotine products. Our focus has been on developing products that can make a real change to the smoking paradigm and to reimagine how smokers consume nicotine.
ENHALE, the first in our pipeline of our medical developments has been CE marked as a medical device in the European Union under the Medical Devices Directive and is currently in development for clinical studies in 2021 to support its marketing authorization within Europe. Extensive research into nicotine delivery, stability and aerosol science has enabled cutting-edge developments in nicotine delivery for a truly safe and effective way to deliver nicotine.
- Lower cost of goods
- Precise nicotine dose
- No thermal degredaants
- Intuitive use
- Sate-of-the-art safety